IFNAR1 and Zika virus infectious disease: Here, we demonstrate that vaccination with a recombinant MVA candidate-vaccine expressing ZIKV-prME-protein (MVA-ZIKV) mediates rapid protection against neurological ZIKV infection as well as in utero-transmission in the IFNAR-/- mouse model.